Company News

BIOLOOP™ is an innovative project to recycle plastic Petri dishes from infectious waste into new reagents packaging—reducing CO₂ emissions and supporting a circular economy in healthcare.

By an interim order dated April 11, 2025, it was held that the press release published on March 3, 2025 on the Qiagen GmbH website constitutes an act of disparagement and unfair competition by Qiagen GmbH and Qiagen N.V. against bioMérieux.

This partnership aims to develop innovative solutions to improve the accuracy and efficiency of in vitro diagnostic tools and detection of antibiotic resistance.

bioMérieux announces a new strategic research partnership with Vall d'Hebron, one of Spain's largest and most prestigious healthcare institutions. This collaboration aims to advance research and development in the areas of infectious diseases, data surveillance, and laboratory automation.

bioMérieux, a world leader in the field of in vitro diagnostics, has finalized the closing of the acquisition of Neoprospecta on January 29th, 2025. A Sale and Purchase Agreement (SPA) to acquire this Brasilian-based company was signed in November 2024. Neoprospecta, based in Florianopolis, develops and markets innovative user-friendly data and genomics solutions for augmenting quality assurance programs and improve microbiological risk prevention in food and pharma industries.